Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-20

FDA Approved: SUNOSI — Original Application (Axsome Therapeutics, Inc.)

View source ↗

Summary

Sunosi (solriamfetol) received FDA approval via an Original Application for the treatment of excessive daytime sleepiness in adults with narcolepsy or obstructi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sunosi (solriamfetol)

Snippet

ORIG AP for SUNOSI (SOLRIAMFETOL)